A dendritic cell-based tumour vaccine for lung cancer: Full-length XAGE-1b protein-pulsed dendritic cells induce specific cytotoxic T lymphocytes in vitro

Clinical and Experimental Immunology

Volumn 153, Issue 3, 2008, Pages 392-400

  Zhou, Q ^a   Guo, A L ^a   Xu, C R ^a   An, S J ^a   Wang, Z ^a   Yang, S Q ^a   Wu, Y L ^a  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Cancer testis antigen; Dendritic cells; Non small cell lung cancer; Tumour immunity; XAGE 1b

Indexed keywords

DENDRITIC CELL VACCINE; MESSENGER RNA; PLASMID VECTOR; PROTEIN XAGE 1B; RECOMBINANT PROTEIN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANTIGENICITY; ARTICLE; CANCER CELL; CANCER IMMUNOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DENDRITIC CELL; EPITHELIUM CELL; EXPRESSION VECTOR; GENE EXPRESSION; GENE INSERTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RECOMBINANT PLASMID; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR IMMUNITY;

ADENOCARCINOMA; ANTIGENS, NEOPLASM; CARCINOMA, NON-SMALL-CELL LUNG; CHINA; DENDRITIC CELLS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; LUNG NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTES, CYTOTOXIC;

EID: 49649114788     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2008.03724.x     Document Type: Article

References (27)

1. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998 392 : 245 52.
2. Van der Bruggen P, Traversari C, Chomez P et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991 254 : 1643 7.
3. Van den Eynde BJ, van der Bruggen P. T cell defined tumor antigens. Curr Opin Immunol 1997 9 : 684 93.
4. Brass N, Heckel D, Sahin U, Pfreundschuh M, Sybrecht GW, Meese E. Translation initiation factor eIF-4gamma is encoded by an amplified gene and induces an immune response in squamous cell lung carcinoma. Hum Mol Genet 1997 6 : 33 9.
5. Sahin U, Türeci O, Schmitt H et al. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA 1995 92 : 11810 13.
6. Chen YT, Güre AO, Tsang S et al. Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library. Proc Natl Acad Sci USA 1998 95 : 6919 23.
7. Scanlan MJ, Gure AO, Jungbluth AA, Old LJ, Chen YT. Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol Rev 2002 188 : 22 32.
8. Scanlan MJ, Simpson AJ, Old LJ. The cancer/testis genes: review, standardization, and commentary. Cancer Immun 2004 4 : 1.
9. Old LJ. Cancer/testis (CT) antigens - a new link between gametogenesis and cancer. Cancer Immun 2001 1 : 1.
10. Davis ID, Chen W, Jackson H et al. Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans. Proc Natl Acad Sci USA 2004 101 : 10697 702.
11. Zhang Y, Sun Z, Nicolay H et al. Monitoring of anti-vaccine CD4 T cell frequencies in melanoma patients vaccinated with a MAGE-3 protein. J Immunol 2005 174 : 2404 11.
12. Nakagawa K, Noguchi Y, Uenaka A et al. XAGE-1 expression in non-small cell lung cancer and antibody response in patients. Clin Cancer Res 2005 11 : 5496 503.
13. Gure AO, Chua R, Williamson B et al. Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer. Clin Cancer Res 2005 11 : 8055 62.
14. Brinkmann U, Vasmatzis G, Lee B, Pastan I. Novel genes in the PAGE and GAGE family of tumor antigens found by homology walking in the dbEST database. Cancer Res 1999 59 : 1445 8.
15. Liu XF, Helman LJ, Yeung C, Bera TK, Lee B, Pastan I. XAGE-1, a new gene that is frequently expressed in Ewing's sarcoma. Cancer Res 2000 60 : 4752 5.
16. Zendman AJ, Van Kraats AA, Weidle UH, Ruiter DJ, Van Muijen GN. The XAGE family of cancer/testis-associated genes: alignment and expression profile in normal tissues, melanoma lesions and Ewing's sarcoma. Int J Cancer 2002 99 : 361 9.
17. Egland KA, Kumar V, Duray P, Pastan I. Characterization of overlapping XAGE-1 transcripts encoding a cancer testis antigen expressed in lung, breast, and other types of cancers. Mol Cancer Ther 2002 1 : 441 50.
18. Ali Eldib AM, Ono T, Shimono M et al. Immunoscreening of a cDNA library from a lung cancer cell line using autologous patient serum: identification of XAGE-1b as a dominant antigen and its immunogenicity in lung adenocarcinoma. Int J Cancer 2004 108 : 558 63.
19. Sato S, Noguchi Y, Ohara N et al. Identification of XAGE-1 isoforms: predominant expression of XAGE-1b in testis and tumors. Cancer Immun 2007 7 : 5 13.
20. Zhou Q, Guo AL, An SJ, Xu CR, Yang SQ, Wu YL. Association of XAGE-1b gene expression with clinical characteristics of non-small cell lung cancer. Nan Fang Yi Ke Da Xue Xue Bao 2007 27 : 966 8 (in Chinese).
21. Zhou Q, Wu YL, Guo AL, Wang K, Xu CR, Yang XN. Rapid in vitro generation of clinical grade dendritic cells in serum-free medium. Zhong Guo Zhong Liu Lin Chuang 2006 33 : 605 7 (in Chinese).
22. Wang X, Cai J, Zhong H, Denham SA, Terasaki PI. Screening of high cytotoxic tumor killer cells using a sensitive adherent target detachment assay. J Immunol Methods 2004 295 : 57 65.
23. Nikitina EY, Clark JI, Van Beynen J et al. Dendritic cells transduced with full-length wild-type p53 generate antitumor cytotoxic T lymphocytes from peripheral blood of cancer patients. Clin Cancer Res 2001 7 : 127 35.
24. Nikitina EY, Chada S, Muro-Cacho C et al. An effective immunization and cancer treatment with activated dendritic cells transduced with full-length wild-type p53. Gene Ther 2002 9 : 345 52.
25. Tokunaga N, Murakami T, Endo Y et al. Human monocyte-derived dendritic cells pulsed with wild-type p53 protein efficiently induce CTLs against p53 overexpressing human cancer cells. Clin Cancer Res 2005 11 : 1312 18.
26. Batchu RB, Moreno AM, Szmania SM et al. Protein transduction of dendritic cells for NY-ESO-1-based immunotherapy of myeloma. Cancer Res 2005 65 : 10041 9.
27. Wang K, Wu YL, Zhou Q, Lin JY, Xu CR, Yang XN. Large-scale generation of mature clinical grade dendritic cells. Zhong Liu Fang Zhi Yan Jiu 2004 31 : 458 60 (in Chinese).